Bioelectronic Medicine

Dr Kevin J Tracey (Editor-in-Chief) is President and CEO and the Karches Family Distinguished Chair in Medical Research at The Feinstein Institutes for Medical Research, Professor of Neurosurgery and Molecular Medicine at the Zucker School of Medicine at Hofstra-Northwell, and Executive Vice President, Research, at Northwell Health in New York. A leader in the scientific fields of neuroimmunology and bioelectronic medicine, his contributions include discovery and molecular mapping neural circuits controlling immunity and identifying the therapeutic action of monoclonal anti-TNF antibodies. Professor Tracey received his B.S. (Chemistry, summa cum laude, Phi Beta Kappa) from Boston College in 1979, and his M.D. from Boston University in 1983. He trained in neurosurgery from 1983 to 1992 at the New York Hospital-Cornell University Medical Center and was a guest investigator at the Rockefeller University before moving in 1992 to The Feinstein Institutes. An inventor on >120 United States patents, and author of more than 400 scientific publications, he cofounded the Global Sepsis Alliance, a non-profit organization supporting the efforts of >1 million sepsis caregivers in more than 70 countries. Dr. Tracey is co-founder of several biotechnology companies, including SetPoint Medical, the industry leader in bioelectronic medicine for developing vagus nerve stimulation technology to treat rheumatoid arthritis. His honors and awards include Doctorates honoris causa from the Karolinska Institute, Stockholm, Sweden; from Hofstra University, New York, and from the University of Fribourg, Switzerland. He received the Distinguished Alumni Award from Boston University; and delivered the Harvey Society lecture in New York, as well as lectureships from Harvard, Yale, Rockefeller University, the NIH, and elsewhere. He was elected into the American Society of Clinical Investigation (2001), the American Association of Physicians (2009), the Long Island Technology Hall of Fame (2012), Alpha Omega Alpha (2014), the American Association for the Advancement of Science (2014), and the American Institute for Medical and Biological Engineering (2020). Professor Tracey is a TedMed speaker and author of Fatal Sequence (Dana Press) and The Great Nerve (Avery). He lectures nationally and internationally on inflammation, sepsis, the neuroscience of immunity, and bioelectronic medicine.

Dr Valentin Pavlov, PhD (Executive Editor) is Professor at the Feinstein Institutes for Medical Research, Northwell Health, and Professor at the Zucker School of Medicine at Hofstra/Northwell. 
He received his PhD in Physiology, Pathophysiology and Pharmacology from Sofia University "St. Kliment Ohridski" in Sofia, Bulgaria. Following a post-doc at Robert Gordon University, Aberdeen, UK, he joined the Feinstein Institutes in 2002.
Dr Pavlov’s current research focuses on the role of the brain and vagus nerve cholinergic signaling in the regulation of inflammation and metabolism, and the use of novel cholinergic therapeutic approaches in sepsis and obesity-driven disorders. 
Dr Pavlov is a member of several scientific societies, including Society for Neuroscience, American Physiological Society, American Association of Immunologists, and American Society for Pharmacology and Experimental Therapeutics. He is an Elected Fellow of the American Institute for Medical and Biological Engineering and President of the International Society for Autonomic Neuroscience.

Dr Sonya VanPatten, PhD (Coordinating Editor) is a research scientist in the Institute of Molecular Medicine at the Feinstein Institutes for Medical Research. Dr. VanPatten received her PhD from the Albert Einstein College of Medicine (Bronx, NY, USA) in the Department of Biochemistry. She later did a post-doc at the Feinstein Institutes in the Department of Medicinal Chemistry.
Dr. VanPatten’s research has been in the fields of lipid metabolism, obesity, immunology and autoimmune disease, neuroscience, and drug discovery and development. Currently, she focuses on scientific writing, synopsis, consultation, project management, and editorial aspects of the Institutes’ journals.

The Editors of Bioelectronic Medicine welcome authors to send any pre-submission inquiries they might have here. We ask that you please include “Pre-submission inquiry” in the subject line of your email and that you include the title and abstract of your proposed submission within the message. Our Editors will do their best to respond to you in a timely manner.

If you enjoy Bioelectronic Medicine, we invite you to visit Feinstein’s flagship journal, Molecular Medicine (published by BMC). Published for nearly a quarter of a century and fully indexed, Molecular Medicine focuses on recent insights into the molecular mechanisms of disease pathogenesis, which may lead to the design of specific tools for disease diagnosis, treatment, or prevention. You will find material relevant to the genetic, molecular, or cellular basis of key physiologic or disease processes, as well as content which describes the clinical implications of these findings, at a level approachable by our broad audience.

Bioelectronic Medicine is published in partnership with The Feinstein Institutes for Medical Research. As the research arm of Northwell Health, the largest healthcare provider in New York, it is home to 50 research laboratories and to clinical research throughout dozens of hospitals and outpatient facilities. The Feinstein Institutes include 4,000 researchers and staff who are making breakthroughs in molecular medicine, genetics, oncology, brain research, mental health, autoimmunity, and bioelectronic medicine – a new field of science that has the potential to revolutionize medicine. For more information about how the Feinstein Institutes empower imagination and pioneers discovery, visit FeinsteinInstitute.org.